D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...
Joint presentation by Orchestra BioMed and Medtronic leadership to discuss ongoing strategic collaboration for development and commercialization ...
A groundbreaking study introduces new noninvasive screening tools that have the potential to greatly enhance patient comfort ...
Ocular manifestations like xanthelasma and arcus corneae are early indicators of high cholesterol and increased ...
Men face higher chronic disease rates after 40. Learn which medical tests doctors say are vital for preventing heart attacks, ...
2 servings of peanuts per day could help improve brain blood flow and preserve brain health as we age, a small trial suggests ...
Philstar.com on MSN
The cost of delay: How late diagnosis is fueling lung cancer deaths
Lung cancer is the deadliest cancer in the Philippines, killing over 20,000 people in 2022 alone. Many of these deaths could have been prevented with earlier diagnosis or access to treatment — but ...
A newly identified cancer pathway may finally reveal how to stop pancreatic tumors before they spread. A Cornell-led research ...
Detailed price information for Ventyx Biosciences Inc (VTYX-Q) from The Globe and Mail including charting and trades.
The beloved actress, who was first diagnosed with age-related macular degeneration (AMD) in 2012, revealed in a candid ...
Dr Sanjay Rajagopalan, Director of the Case Cardiovascular Research Institute, is winner of 2025 American Heart Association (AHA) Distinguished Scientist Award.
Ocular intends to submit AXPAXLI New Drug Application (NDA) for wet AMD shortly after year one data from SOL-1, if positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback